세계의 자폐증 스펙트럼 진단 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

The global demand for Autism Spectrum Disorder Diagnostics Market is presumed to reach the market size of nearly USD 44.82 BN by 2032 from USD 27.52 BN in 2023 with a CAGR of 5.57% under the study period 2024 - 2032.

Autism Spectrum Disorder (ASD) Diagnostics involve the assessment and identification of autism-related characteristics in individuals. Diagnostic processes may include behavioral observations, interviews, and standardized tests to evaluate communication skills, social interactions, and repetitive behaviors.

MARKET DYNAMICS

The Autism Spectrum Disorder Diagnostics market is driven by the increasing prevalence of ASD, growing awareness, and the need for early and accurate diagnosis. These diagnostics involve a range of assessments, including behavioral evaluations, genetic testing, and neuroimaging, to identify and characterize autism spectrum disorders in individuals. The rising recognition of the importance of early intervention in improving outcomes for individuals with ASD stimulates the demand for reliable and comprehensive diagnostic tools. Additionally, advancements in medical imaging technologies contribute to accurate and timely diagnoses. The expanding awareness of ASD across healthcare professionals, educators, and parents further fuels the demand for diagnostics. Regulatory support for autism research and diagnostic development also plays a pivotal role in market growth. Moreover, ongoing research efforts focused on identifying biomarkers, genetic factors, and neurodevelopmental indicators aim to enhance the precision and efficiency of ASD diagnostics, shaping the trajectory of this market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of autism spectrum disorder diagnostics. The growth and trends of autism spectrum disorder diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the autism spectrum disorder diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• Autistic Disorder
• Asperger Syndrome
• Pervasive Development Disorder (Pdd)
• Other

By Service

• Behavioral Approaches
• Early Intervention
• Medication
• Other

By Distribution Channe

• Hospital Pharmacies
• Drug Stores And Retail Pharmacies
• Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Autism Spectrum Disorder Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Autism Spectrum Disorder Diagnostics market include Quest Diagnostics, Bio-Rad Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Abbott Laboratories, Koninklijke Philips N.V. (Philips Healthcare), PerkinElmer Inc., GE Healthcare, Agilent Technologies, and others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . AUTISM SPECTRUM DISORDER DIAGNOSTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Service
  • 3.7.3 Market Attractiveness Analysis By Distribution Channe
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET ANALYSIS BY TYPE

• 5.1 Overview by Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Type
• 5.4 Autistic Disorder Historic and Forecast Sales by Regions
• 5.5 Asperger Syndrome Historic and Forecast Sales by Regions
• 5.6 Pervasive Development Disorder (PDD) Historic and Forecast Sales by Regions
• 5.7 Other Historic and Forecast Sales by Regions

6 . GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET ANALYSIS BY SERVICE

• 6.1 Overview by Service
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Service
• 6.4 Behavioral Approaches Historic and Forecast Sales by Regions
• 6.5 Early Intervention Historic and Forecast Sales by Regions
• 6.6 Medication Historic and Forecast Sales by Regions
• 6.7 Other Historic and Forecast Sales by Regions

7 . GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET ANALYSIS BY DISTRIBUTION CHANNE

• 7.1 Overview by Distribution Channe
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Distribution Channe
• 7.4 Hospital Pharmacies Historic and Forecast Sales by Regions
• 7.5 Drug Stores and Retail Pharmacies Historic and Forecast Sales by Regions
• 7.6 Online Pharmacies Historic and Forecast Sales by Regions

8 . GLOBAL AUTISM SPECTRUM DISORDER DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE AUTISM SPECTRUM DISORDER DIAGNOSTICS COMPANIES

• 9.1. Autism Spectrum Disorder Diagnostics Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF AUTISM SPECTRUM DISORDER DIAGNOSTICS INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Quest Diagnostics
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Bio-Rad Laboratories
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Thermo Fisher Scientific
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. F. Hoffmann-La Roche Ltd
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Siemens Healthineers
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Abbott Laboratories
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Koninklijke Philips N.V. (Philips Healthcare)
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. PerkinElmer Inc.
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. GE Healthcare
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies